Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC)

QR Code

Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC)

Markus Groppe,* Mandeep Singh Bindra* Retina Unit, Buckinghamshire Healthcare NHS Trust, Stoke Mandeville and Amersham Hospital, Aylesbury, HP21 8AL, UK*These authors contributed equally to this workCorrespondence: Markus GroppeRetina Unit, Buckinghamshire Healthcare NHS Trust, Stoke Mandeville and...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Groppe M, Bindra MS
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	age related macular degeneration covid-19 social distancing sdoc Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/f5e283b0b1784caa9bb08e9ea9aff40a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Microcurrent stimulation in the treatment of dry and wet macular degeneration
par: Chaikin L, et autres
Publié: (2015)

Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid
par: Joseph Juliano, et autres
Publié: (2021)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
par: M. M. Bikbov, et autres
Publié: (2019)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
par: Dervenis N, et autres
Publié: (2016)

Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
par: Suetsugu T, et autres
Publié: (2016)

Management of neovascular age-related macular degeneration: Taiwan expert consensus
par: Ling Yeung, et autres
Publié: (2021)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
par: Amoaku W, et autres
Publié: (2018)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
par: Kabanarou SA, et autres
Publié: (2017)

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
par: Kaya C, et autres
Publié: (2019)

Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
par: Muste JC, et autres
Publié: (2021)

Optimized Prediction Models from Fundus Imaging and Genetics for Late Age-Related Macular Degeneration
par: Arun Govindaiah, et autres
Publié: (2021)

Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
par: Jacek Dziedziak, et autres
Publié: (2021)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
par: Chakraborty D, et autres
Publié: (2021)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
par: Fong AH, et autres
Publié: (2013)

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
par: Kaya A
Publié: (2016)

Questionnaire Survey on Driving among Patients with Age-Related Macular Degeneration in Japan
par: Chikako Hara, et autres
Publié: (2021)

Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
par: Hector SM, et autres
Publié: (2017)

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
par: Dimitrios A Karagiannis, et autres
Publié: (2009)

Melatonin level as a risk factor for age-related macular degeneration
par: N. S. Khodzhaev, et autres
Publié: (2021)

CYTOKINES IN LACRIMAL FLUID AND BLOOD SERUM: EARLY BIOMARKERS OF AGE-RELATED MACULAR DEGENERATION
par: O. S. Slepova, et autres
Publié: (2015)

Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration
par: Supanji S, et autres
Publié: (2021)

Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study
par: Thapa R, et autres
Publié: (2017)

Recent developments in age-related macular degeneration: a review
par: Al-Zamil WM, et autres
Publié: (2017)

Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degeneration
par: Taipale C, et autres
Publié: (2018)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
par: Bhagat D, et autres
Publié: (2020)

The burden of neovascular age-related macular degeneration: a patient’s perspective
par: Spooner KL, et autres
Publié: (2018)

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
par: Yan Lu, et autres
Publié: (2021)

Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
par: Yannuzzi NA, et autres
Publié: (2019)

PERIPHERAL BLOOD SUBPOPULATION OF LYMPHOCYTES OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
par: N. V. Balatskaya, et autres
Publié: (2015)

Quantitative Imaging Biomarkers in Age-Related Macular Degeneration and Diabetic Eye Disease: A Step Closer to Precision Medicine
par: Gagan Kalra, et autres
Publié: (2021)

Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients
par: Mahgoub MY, et autres
Publié: (2020)

The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
par: Varano M, et autres
Publié: (2016)

To Peel or Not to Peel: Pars Plana Vitrectomy with Macular Membrane Peel in Eyes with Abnormalities of Vitreomacular Interface and Coexisting Dry Age-Related Macular Degeneration
par: Furashova O, et autres
Publié: (2020)

Identification of lncRNAs involved in biological regulation in early age-related macular degeneration
par: Zhu W, et autres
Publié: (2017)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
par: Elfandi S, et autres
Publié: (2021)

Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
par: Spooner K, et autres
Publié: (2017)

Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
par: Hanumunthadu D, et autres
Publié: (2017)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
par: Gallemore RP, et autres
Publié: (2017)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
par: Sabrina L. Mitchell, et autres
Publié: (2021)

Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process
par: Alfredo García-Layana, et autres
Publié: (2021)